Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
about
Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate.Glucocerebrosidase Mutations in Parkinson Disease.The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.Progress toward an integrated understanding of Parkinson's disease.Ambroxol for the treatment of fibromyalgia: science or fiction?Chaperone-Based Therapies for Disease Modification in Parkinson's Disease.The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice.α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.Alpha-synuclein, proteotoxicity and Parkinson's disease: Search for neuroprotective therapy.Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons.Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.Heterozygous carriers of galactocerebrosidase mutations that cause Krabbe disease have impaired microglial function and defective repair of myelin damage.Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins.Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice.Modeling Parkinson's Disease in Drosophila: What Have We Learned for Dominant Traits?Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.Centrality of Early Synaptopathy in Parkinson's Disease.Is Parkinson's disease a lysosomal disorder?
P2860
Q33835745-5427DB1D-24CB-40AA-A83B-40A3D9E00B5DQ39362339-87FD2A22-9A65-4FCF-92B9-15EA3323C102Q39410832-FD7462FA-88BE-4D68-AD7D-08E0BDBBD3C6Q40114382-E11317CA-AFE5-4EF3-8F09-3DBB81913AEEQ40196691-BF4BCB4B-702A-4491-900D-F0C0BB9255D9Q41012014-BA29E4D3-E2D9-49AB-871A-7AF92328EF97Q41483222-2CEEEA14-6A02-4A21-B6DA-6F3720D7B471Q41623081-FC2A3CC3-CDA1-49EC-A0BE-68526DC7587CQ41926295-13C5CC7C-5207-478E-A4CE-778F483D6FE0Q47193560-8BE45880-E802-4941-B1AE-5209E6C412A1Q47348189-A843DEBC-8E79-47BF-AA01-460D82DC1EF5Q48181256-18EE64EE-2306-4708-A7A9-46F6DE288E4AQ50424585-C1011617-75E9-4A55-BD4B-677FC6D3B4CAQ52330247-E08B6BBE-395A-44D5-A26A-77CEDB5AB160Q53813036-744ADA60-B7EB-4774-AC50-DC242900A61DQ53819711-C7398994-C421-499E-8188-02B0CEA84E81Q54114687-C7BF3CB8-BBE9-4200-9D3E-6D87CDFF5292Q55048859-02A6B19F-74D1-4604-97D6-59DD22D5855BQ55071517-4FE9FA88-6141-41D6-A82A-5F713FB94B76Q58479932-02FC7DE9-A6EB-4F58-BE3B-00BDD5A7989D
P2860
Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
@en
Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
@nl
type
label
Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
@en
Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
@nl
prefLabel
Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
@en
Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
@nl
P2860
P356
P1433
P1476
Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
@en
P2093
Erwan Bezard
P2860
P304
P356
10.1002/ANA.24790
P577
2016-11-01T00:00:00Z